We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Transseptal Access Dilator Facilitates LAA Closure

By HospiMedica International staff writers
Posted on 16 May 2019
Print article
Image: The ExpanSure Transseptal Dilation System (Photo courtesy of Baylis Medical).
Image: The ExpanSure Transseptal Dilation System (Photo courtesy of Baylis Medical).
A new dilation system with a larger diameter optimizes left-heart procedures that require a large sheath to cross the heart's septum from the right atrium.

The Baylis Medical (Montreal, Canada) ExpanSure Transseptal Dilation System combines a sheath and dilator into a single braided composite tool, eliminating the traditional dilator-sheath transition that demands the use of added force to achieve crossing and allowing larger dilations, when compared to the standard fixed curve sheath. The system is intended for procedures such as left-atrial appendage (LAA) closure and balloon ablation for atrial fibrillation (AF). Features include a 12.5 Fr outer diameter, which pre-dilates the transseptal puncture, and a 0.035" inner diameter that allows physicians to engage their preferred wire without having to exchange for a compatible dilator.

“Crossing a 14 F sheath across the septum is often challenging, and, in certain cases, additional devices are needed to facilitate left-atrial access. Research has shown that introducing additional dilation devices may result in adverse events to the patient,” said Oussama Wazni, MD, section head of electrophysiology at the Cleveland Clinic (CC; OH, USA), who performed the first ExpanSure clinical case in the US. “Clinical evidence has shown that the dilator-sheath transition found in typically-used devices can cause septal tissue to get caught, resulting in difficulty crossing the septum.”

“Baylis is proud to offer a device uniquely designed to optimize transseptal access, allowing the physician's primary focus to remain on delivering the necessary therapy to the patient,” said Robert Harrison, director of research and development in cardiology at Baylis Medical. “We are delighted to have partnered with Dr. Wazni and the Cleveland Clinic for this successful first clinical use.”

Access to the left side of the heart is required for various therapies, including pulmonary vein isolation (PVI), mitral valve repair, and LAA closure. These procedures are typically performed through an atrial septal puncture. Once access to the left atrium is achieved, the role of a transseptal sheath and dilator set differs depending on the therapy being performed. Although the use of the sheath may vary, the ability to precisely control the distal end of the sheath during the atrial septal puncture is a common requirement.

Related Links:
Baylis Medical
Cleveland Clinic

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Examination Table
Powerline Backrest Top

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.